RESEARCHER PROFILE

Ekhlas Khammas Hasan

← Back to Al-Bayan University

E

Al-Bayan University

Pharmacogenetics and Drug MetabolismChronic Myeloid Leukemia TreatmentsDrug Transport and Resistance MechanismsIron Metabolism and DisordersTrace Elements in Health

Ekhlas Khammas Hasan works in Pharmacogenetics and Drug Metabolism, Chronic Myeloid Leukemia Treatments, Drug Transport and Resistance Mechanisms, Iron Metabolism and Disorders, Trace Elements in Health. Recorded institutional associations include Al-Bayan University.

14Publications
65Citations
3H-index

Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.

Selected research works

Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.

  1. Neuroprotective effects of riluzole in Alzheimer's disease: A comprehensive review

    2023 · 31 citations

  2. Protective effects of pioglitazone in renal ischemia–reperfusion injury (RIRI): focus on oxidative stress and inflammation

    2024 · 20 citations

  3. Hyperbaric Oxygen in Combination with Epigallocatechin-3-Gallate Synergistically Enhance Recovery from Spinal Cord Injury in Rats

    2023 · 8 citations

  4. EFFECT OF MAGNESIUM L!LACTATE SUPPLEMENT ON BLOOD PRESSURE AND CORRECTED QT INTERVAL IN A SAMPLE OF IRAQI WOMEN WITH METABOLIC SYNDROME

    2023 · 3 citations

  5. The clinical applications of ferritin

    2022 · 2 citations

  6. Impact of MDR-1 Gene Polymorphism (rs1128503) on Response to Imatinib or Nilotinib in Iraqi Patients with Chronic Myeloid Leukemia: An Observational Study

    2024 · 1 citations

  7. Nigella sativa Seed Oil Antibacterial and Antibiofilm Activity against Escherichia coli O157H7 Shiga Toxin-2

    2026 · 0 citations

  8. DEEP LEARNING-BASED INVESTIGATION FOR ROOT DISEASE CLASSIFICATION

    2025 · 0 citations

  9. Underlying data for The Impact of ABCB1 (rs1045642 and rs117068084) Gene Polymorphisms on Response to Imatinib Treatment in A Sample of Iraqi Chronic Myeloid Leukemia-Chronic Phase Patients

    2023 · 0 citations

  10. Article data of The Impact of MDR-1 Gene Polymorphism (rs1128503) on Response to Imatinib and nilotinib Treatment in A Sample of Iraqi Chronic Myeloid Leukemia-Chronic Phase Patients

    2023 · 0 citations

  11. Article data of The Impact of MDR-1 Gene Polymorphism (rs1128503) on Response to Imatinib and nilotinib Treatment in A Sample of Iraqi Chronic Myeloid Leukemia-Chronic Phase Patients

    2023 · 0 citations

  12. Prevalence of antibiotic use among medical students in Iraq

    2021 · 0 citations

← Return to the university profile